TickerFacts.

Company research / SYK

Stryker Corp (SYK)

Build a valuation ↗↓ Download CSV

SEC name STRYKER CORP · CIK 0000310764 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated MI
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Stryker Corp reported revenue of $25.12B. Revenue grew 11.2% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $25.84B.

Key ratios (year ended 2025-12-31)

64.0%
Gross margin
19.5%
Operating margin
12.9%
Net margin
14.5%
Return on year-end equity
11.2%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-06

Headquarters locality: Portage · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$25.84B$25.12B$22.59B$20.50B$18.45B$17.11B$14.35B$14.88B$13.60B$12.44B$11.32B
Cost of Revenue$9.05B$9.05B$8.15B$7.44B$6.87B$6.14B$5.29B$5.19B$4.66B$4.26B$3.82B
Gross Profit$16.79B$16.07B$14.44B$13.06B$11.58B$10.97B$9.06B$9.70B$8.94B$8.18B$7.50B
R&D Expense$1.66B$1.62B$1.47B$1.39B$1.45B$1.24B$984.00M$971.00M$862.00M$787.00M$715.00M
Operating Income$5.53B$4.89B$3.69B$3.89B$2.84B$2.58B$2.22B$2.71B$2.54B$2.30B$2.17B
Depreciation & Amortizationn/a$1.57B$1.43B$1.34B$1.28B$1.27B$1.08B$1.04B$966.00M$859.00M$752.00M
EBITDAn/a$6.46B$5.12B$5.23B$4.12B$3.86B$3.30B$3.76B$3.50B$3.16B$2.93B
Net Income$3.73B$3.25B$2.99B$3.17B$2.36B$1.99B$1.60B$2.08B$3.55B$1.02B$1.65B
EPS (Diluted)n/a$8.40$7.76$8.25$6.17$5.21$4.20$5.48$9.34$2.68$4.35
Total Assets$47.93B$47.84B$42.97B$39.91B$36.88B$34.63B$34.33B$30.17B$27.23B$22.20B$20.43B
Total Liabilities$23.94B$25.42B$22.34B$21.32B$20.27B$19.75B$21.25B$17.36B$15.50B$12.22B$10.88B
Shareholders' Equity$23.99B$22.42B$20.63B$18.59B$16.62B$14.88B$13.08B$12.81B$11.73B$9.98B$9.55B
Cash & Equivalents$3.39B$4.01B$3.65B$2.97B$1.84B$2.94B$2.94B$4.34B$3.62B$2.54B$3.32B
Operating Cash Flow$5.53B$5.04B$4.24B$3.71B$2.62B$3.26B$3.28B$2.19B$2.61B$1.56B$1.92B
Capital Expenditures$823.00M$761.00M$755.00M$575.00M$588.00M$525.00M$487.00M$649.00M$572.00M$598.00M$490.00M
Free Cash Flow$4.70B$4.28B$3.49B$3.14B$2.04B$2.74B$2.79B$1.54B$2.04B$961.00M$1.43B
Share Repurchasesn/an/an/an/an/a$0$0$307.00M$300.00M$230.00M$13.00M
Dividends Paid$1.32B$1.28B$1.22B$1.14B$1.05B$950.00M$863.00M$778.00M$703.00M$636.00M$568.00M
Shares Outstandingn/an/an/an/an/an/an/an/an/a374.40M374.60M
Dividends Per Sharen/an/an/an/an/an/an/an/an/an/a$1.56
Weighted Average Diluted Sharesn/a386.50M385.60M383.70M382.20M382.30M380.30M379.90M380.30M380.10M378.50M
EPS (Basic)n/a$8.49$7.86$8.34$6.23$5.29$4.26$5.57$9.50$2.73$4.40

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView